SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020483
Filing Date
2018-08-08
Accepted
2018-08-08 16:16:33
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20180630.htm 10-Q 1928392
2 EX-10.1 sndx-ex101_116.htm EX-10.1 28025
3 EX-31.1 sndx-ex311_6.htm EX-31.1 10286
4 EX-31.2 sndx-ex312_9.htm EX-31.2 10734
5 EX-32.1 sndx-ex321_7.htm EX-32.1 11878
  Complete submission text file 0001564590-18-020483.txt   6786063

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sndx-20180630.xml EX-101.INS 1571904
7 XBRL TAXONOMY EXTENSION SCHEMA sndx-20180630.xsd EX-101.SCH 44875
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20180630_cal.xml EX-101.CAL 41031
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20180630_def.xml EX-101.DEF 132474
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20180630_lab.xml EX-101.LAB 294634
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20180630_pre.xml EX-101.PRE 251470
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 181001555
SIC: 2834 Pharmaceutical Preparations